As recently as April, 17 pure-play pot stocks — i.e., not thes of the world that rely on cannabis as a small percentage of their sales — were lugging around a market cap of at least $1 billion. This was the result of robust growth projections for the marijuana industry that forecast anywhere from $50 billion to$200 billion in annual worldwide salesin a decades time.
But a lot has changed in just a few months. Supply challenges in Canada have remained persistent, and will take numerous quarters to solve. Meanwhile, high tax rates on legal cannabis in the U.S. have fueled the black market and dragged down sales in leading markets, such as California. The result has been weaker stock performances and shrinking valuations.
As of the closing bell this past Monday, just 13 pot stocks still possessed a billion-dollar valuation, with 7 of these 13 just $570 million, or less, away from dropping out of the billion-dollar club. In descending order by market, here are the largest marijuana stocks in the world.
The biggest cannabis stock by a mile, and the only true large-cap pot stock, continues to beCanopy Growth(NYSE: CGC). Canopy will likely slot in as the second-largest grower in Canada, with north of 500,000 kilos a year when at peak capacity. Its also done a bang-up job of pushing into the U.S. hemp industry, and nabbedAcreage Holdings(NASDAQOTH: ACRGF)via a $3.4 billion contingent-rights cash-and-stock deal, when announced. As one last add-on, Canopy Growth hasaround $3.4 billion in cash and cash equivalentsat its disposal, which provides a nice foundation for its large-cap valuation.
Although its flirted with large-cap territory for short periods of time,Aurora Cannabis(NYSE: ACB)has firmly established itself as the second-largest pot stock by market cap. Auroras primary means of growth has been through acquisitions, of which its made 15 since August 2016. This is a company thatsprojected to lead all growers in peak annual production, and has established a more diverse geographic presence than any other weed stock.
The only pure-play cannabinoid-based drug stock on this list,GW Pharmaceuticals(NASDAQ: GWPH)ranks third in market cap among cannabis stocks. GW Pharmaceuticals had the first-ever cannabis-derived drug, Epidiolex, approved by the U.S. Food and Drug Administration in June 2018. After a slow launch, net sales of the drugreally picked up in the first quarter, to $33.5 million. As the only company with an approved treatment for Dravet syndrome (Epidiolex also is approved to treat Lennox-Gastaut syndrome), GW Pharmaceuticals looks to have a clear runway to ramp up sales of its cannabidiol (CBD)-based drug.
Having been unseated by GW Pharma, cannabinoid company and growerCronos Group(NASDAQ: CRON)is fourth with a market cap of nearly $4.9 billion. Much of Cronos Groups valuation comes from the45% nondiluted stake Altria took in the company, which closed in March. As a result, Cronos sports a healthy $1.8 billion in cash on its balance sheet. This is a company with a clear focus on the derivatives market via vapes and commercial cannabinoids, which should begin taking off in mid-December.
Former highflierTilray(NASDAQ: TLRY), which briefly doubled-up Canopy Growth in market cap last September, has dipped all the way to the No. 5 spot but still sports a $4.1 billion market cap. Supporting this valuation is Tilrays access to medical patients in more than a dozen countries, as well as its push into the U.S. via itsacquisition of hemp foods company Manitoba Harvestin March 2019. Manitoba Harvest has a distribution network with access to more than 16,000 retailers, which is perfect given Tilrays desire to reach new markets with CBD products.
Vertically integrated dispensary operatorCuraleaf Holdings(NASDAQOTH: CURLF)rounds out the last of the true midcap marijuana stocks at nearly $3.7 billion. Already the leader in operational retail stores, Curaleaf announced theacquisition of multistate operator Grassrootson July 17 for $875 million in cash and stock. This builds on Curaleafs purchase of Cura Partners, which owns the Select brand, earlier this year. When all of its deals are closed, Curaleaf will have access to 19 states and will be able to open up to 131 retail locations.
Theres a more than $2 billion gap between Curaleaf and the next-closest dispensary operator in terms of market cap, Green Thumb Industries (NASDAQOTH: GTBIF). Green Thumb operates in a dozen states and has 89 licenses in its portfolio for retail locations. That makes it a clear top five player in the U.S. with its Rise-branded stores. Of note, Green Thumb hastaken particular interest in the Nevada market, which has some of the highest projected per-capita spending on legal cannabis in the United States.
Once upon a time a much larger company in terms of market cap,Aphria(NYSE: APHA) has beenhammered by investor trust issues. Even though Aphria looks to be the third-largest grower in Canada, with 255,000 kilos of peak annual output, and has devoted a good portion of its portfolio to derivatives (when they go on sale in mid-December), investors are struggling to put conflicts of interest uncovered in the early part of 2019 in the rearview mirror. Nevertheless, it remains the eighth-largest pot stock, albeit fractionally ahead of the next company on this list.
Landing at No. 9 is yet another vertically integrated multistate cannabis operator, Harvest Health & Recreation (NASDAQOTH: HRVSF). Harvest Health has been aggressively acquiring businesses and licenses over the past year, with its biggest deal being the $850 million all-stock purchase of Verano Holdings. On a pro forma basis, Harvest Health has more than 210 aggregate licenses (this includes stores, farms, and processing sites),142 of them for dispensaries. This means Harvest Health can actually open more retail locations than Curaleaf, although Curaleaf has far more operational locations at the moment than Harvest Health.
The always-popular cannabis real estate investment trustInnovative Industrial Properties(NYSE: IIPR)has worked its way into the top 10, even with a very recent share-price swoon. Innovative Industrial has more than doubled the number of marijuana properties in its portfolio this year to 23, and maintains anaverage return on invested capital of 14.7%, implying a complete payback of its invested capital of less than five years. The icing on the cake is a 3.25% annual increase to the rental rates of its 23 properties, providing modest organic operating growth.
Quebec-basedHEXO(NYSE: HEXO)is hanging onto its billion-dollar valuation after a multimonth downtrend, although it is still one of the most de-risked pot stocks in the industry. Around 30% of its output through 2023 is likely headed to its home province of Quebec via amassive wholesale supply dealsigned in 2018. HEXO has also been actively arranging for the third-party extraction of hemp and cannabis biomass, and has more than 600,000 square feet of processing capability of its own to take advantage of higher-margin derivative products.
As noted, multistate operator Acreage Holdings hasagreed to be acquired by Canopy Growthif the U.S. federal government legalizes marijuana. In the meantime, Acreage continues to expand its reach. It holds 88 retail store licenses, which is also in the top five among dispensary operators, and has a presence in 20 U.S. states, which is tops in the industry. Acreage is also forecast to hit nearly $500 million in sales for 2020, potentially making it one of the highest revenue-generating pot stocks.
Rounding out the billion-dollar marijuana stock list at lucky No. 13 is Floridas ownTrulieve Cannabis(NASDAQOTH: TCNNF). Although Trulieve has operations in three other states, its primarily focused on Floridas medical marijuana legal market, where it currently has 29 open retail locations. As one of the very few cannabis stocks to beprofitable on an operating basis, Trulieve has channeled its strong earnings growth and successful branding into a billion-dollar valuation.
Give The 13 largest marijuana stocks in the world 1/5
Give The 13 largest marijuana stocks in the world 2/5
Give The 13 largest marijuana stocks in the world 3/5
Give The 13 largest marijuana stocks in the world 4/5
Give The 13 largest marijuana stocks in the world 5/5
420 Intel is the leading source for cannabis news from around the world. Get the latest updates on cannabis legalization, politics and technology, as well as developments in medical andrecreational marijuana news. Our commitment is to bring you the most important cannabis news stories every day of the week.
At 420 Intel we understand that effective marijuana industry news coverage is a constant endeavor. Every day stories develop regarding cannabis legalization, technological developments, and themedicinal benefits of marijuanause. Each new development carries the potential to impact the marijuana industry regionally, nationally, and internationally. 420 Intel is the marijuana industry news outlet that will keep you up to date on these developments and how they impact the world around you.
With the marijuana industry constantly evolving, you need a cannabis news outlet to keep you abreast of the pertinent information. At 420 Intel, we cover marijuana legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.
You can get 420 Intel news delivered directly to your inbox bysigning upfor our daily marijuana news, ensuring youre always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us onTwitterFacebookandLinkedIn.
420 Intel is your source for up to date news on the marijuana industry.